Immunohistochemical analysis further identified immunoreactive GLUT5 expression within these tumor tissues, which indicates its potential involvement in tumor formation and presents it as a candidate for therapeutic targeting (Bono et al. 2017). Here, SLC2A5 is linked to neoplasm.